StockNews.com upgraded shares of Innospec (NASDAQ:IOSP – Free Report) from a hold rating to a buy rating in a research note released on Thursday.
Innospec Price Performance
IOSP opened at $100.62 on Thursday. Innospec has a one year low of $97.13 and a one year high of $133.71. The company’s 50 day simple moving average is $108.89 and its 200-day simple moving average is $111.92. The stock has a market capitalization of $2.51 billion, a P/E ratio of 70.86 and a beta of 1.08.
Innospec (NASDAQ:IOSP – Get Free Report) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.05. Innospec had a net margin of 1.93% and a return on equity of 12.27%. The firm had revenue of $466.80 million for the quarter, compared to analysts’ expectations of $447.43 million. As a group, analysts anticipate that Innospec will post 6.18 EPS for the current year.
Insider Activity at Innospec
Institutional Investors Weigh In On Innospec
Several hedge funds and other institutional investors have recently added to or reduced their stakes in IOSP. New York State Teachers Retirement System increased its stake in Innospec by 2.6% in the 3rd quarter. New York State Teachers Retirement System now owns 14,781 shares of the specialty chemicals company’s stock valued at $1,672,000 after buying an additional 371 shares during the last quarter. US Bancorp DE increased its stake in Innospec by 323.6% in the 3rd quarter. US Bancorp DE now owns 5,490 shares of the specialty chemicals company’s stock valued at $621,000 after buying an additional 4,194 shares during the last quarter. Leeward Investments LLC MA increased its stake in Innospec by 22.4% in the 3rd quarter. Leeward Investments LLC MA now owns 86,004 shares of the specialty chemicals company’s stock valued at $9,726,000 after buying an additional 15,750 shares during the last quarter. Crossmark Global Holdings Inc. increased its stake in Innospec by 23.7% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 2,286 shares of the specialty chemicals company’s stock valued at $258,000 after buying an additional 438 shares during the last quarter. Finally, State of New Jersey Common Pension Fund D increased its stake in Innospec by 17.8% in the 3rd quarter. State of New Jersey Common Pension Fund D now owns 17,409 shares of the specialty chemicals company’s stock valued at $1,969,000 after buying an additional 2,625 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors and hedge funds.
Innospec Company Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
See Also
- Five stocks we like better than Innospec
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- How to Invest in Blue Chip Stocks
- 3 Stocks to Buy While Others Stay on the Sidelines
- How to Calculate Retirement Income: MarketBeat’s Calculator
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.